{"pageContent": "Background: With the increasing use of robotic surgery in the United States, the comparative effectiveness and differences in reimbursement of minimally invasive radical prostatectomy (MIRP) and open prostatectomy (ORP) in privately insured patients are unknown. Therefore, we sought to assess the differences in perioperative outcomes and hospital reimbursement in a privately insured patient population who were surgically treated for prostate cancer.", "metaData": {"source": "The role for surgery in high-risk prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/26399721/"}}